Temporal arteritis pathophysiology: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(46 intermediate revisions by the same user not shown)
Line 4: Line 4:


==Overview==
==Overview==
The exact pathogenesis of [disease name] is not fully understood.
Temporal arteritis is caused by transmural [[inflammation]] of elastic [[Artery|arteries]]. It is understood that temporal arteritis is the result of [[Cell-mediated immunity|cell mediated immunity]] which arises as a response to [[Endothelium|endothelial]] injury and is antigen-driven disease with [[T cell|T-cell]] and [[macrophage]] activation in the [[Elastic fiber|elastic tissue]] in the [[Artery|arterial]] walls. The [[adventitia]] of the [[Blood vessel|vessel]] is the initial site of immunologic injury. The activation of [[Dendritic cell|dendritic cells]] in the [[adventitia]] causes a production of [[Chemokine|chemokines]] that recruit CD4+ [[T helper cell|T helper cells]]. The CD4+ [[T helper cell]] convert in to [[T helper 17 cell|Th17]] cells which produce [[interleukin 17]] and [[T helper cell|Th1]] cells which produce [[interferon gamma]]. [[Large cell|Giant cell]] are one of many [[Inflammation|inflammatory]] cells that are recruited and produce growth factor which narrows and obstructs the [[Blood vessel|vessels]]. The concentric [[inflammation]] occurs in segments. [[Macrophage|Macrophages]] in the [[adventitia]] produce [[interleukin 6]]. While in the [[Tunica intima|intima]] and media of the [[Blood vessel|vessel]], [[Macrophage|macrophages]] produce [[Vascular endothelial growth factor (VEGF) IRES A|vascular endothelial growth factor (VEGF)]] and [[Metalloproteinase|metalloproteinases]] which destroy the [[internal elastic lamina]]. An increased activated platelets express [[P-selectin]] which may cause [[Blood vessel|vessel]] [[inflammation]] and [[Thrombosis|thromboembolic]] events. Temporal arteritis arises from [[Macrophage|giant cells]], which are fused [[Monocyte|monocytes]] cells that are normally involved in the body [[Immunity (medical)|immune]] response. Because the disease involves only arteries with [[internal elastic lamina]], the [[aortic arch]] and its branches are often involved. Intracranial [[Artery|arteries]] do not have internal elastic lamina and are not involved.


OR
==Pathophysiology==
===Pathogenesis===
*Temporal arteritis is the result of [[Cell-mediated immunity|cell mediated immunity]] which arises as a response to [[Endothelium|endothelial]] injury and is an antigen-driven disease with local [[T cell|T-cell]] and [[macrophage]] activation in the [[Elastic artery|elastic]] tissue of [[Artery|arterial]] walls with an important role of the [[Inflammation|proinflammatory]] [[Cytokine|cytokines]].<ref name="SalvaraniPipitone2007">{{cite journal|last1=Salvarani|first1=C.|last2=Pipitone|first2=N.|last3=Boiardi|first3=L.|last4=Hunder|first4=G. G|title=Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?|journal=Annals of the Rheumatic Diseases|volume=67|issue=5|year=2007|pages=577–579|issn=0003-4967|doi=10.1136/ard.2007.086330}}</ref><ref name="pmid11755863">{{cite journal| author=Pache M, Kaiser HJ, Haufschild T, Lübeck P, Flammer J| title=Increased endothelin-1 plasma levels in giant cell arteritis: a report on four patients. | journal=Am J Ophthalmol | year= 2002 | volume= 133 | issue= 1 | pages= 160-2 | pmid=11755863 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11755863  }} </ref><ref name="pmid12358224">{{cite journal| author=Patel SJ, Lundy DC| title=Ocular manifestations of autoimmune disease. | journal=Am Fam Physician | year= 2002 | volume= 66 | issue= 6 | pages= 991-8 | pmid=12358224 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12358224  }} </ref><ref name="pmid28275606">{{cite journal| author=Wang AL, Raven ML, Surapaneni K, Albert DM| title=Studies on the Histopathology of Temporal Arteritis. | journal=Ocul Oncol Pathol | year= 2017 | volume= 3 | issue= 1 | pages= 60-65 | pmid=28275606 | doi=10.1159/000449466 | pmc=5318845 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28275606  }} </ref>
*The [[adventitia]] of the [[Blood vessel|vessel]] is the initial site of [[Immunology|immunologic]] injury. The activation of [[Dendritic cell|dendritic cells]] in the [[adventitia]] causes a production of [[Chemokine|chemokines]] that recruit [[CD4]]+ [[T helper cell|T helper cells]]. The [[CD4|CD4+]] [[T helper cell]] convert in to [[T helper 17 cell|Th17]] cells which produce [[interleukin 17]] and [[T helper cell|Th1]] cells which produce [[Interferon gamma|interferon gamma.]]
*[[Large cell|Giant cell]] are one of many [[Inflammation|inflammatory]] cells that are recruited and produce [[growth factor]] which narrows and obstructs the [[Blood vessel|vessels]].<ref name="SamsonCorbera-Bellalta2017">{{cite journal|last1=Samson|first1=Maxime|last2=Corbera-Bellalta|first2=Marc|last3=Audia|first3=Sylvain|last4=Planas-Rigol|first4=Ester|last5=Martin|first5=Laurent|last6=Cid|first6=Maria Cinta|last7=Bonnotte|first7=Bernard|title=Recent advances in our understanding of giant cell arteritis pathogenesis|journal=Autoimmunity Reviews|volume=16|issue=8|year=2017|pages=833–844|issn=15689972|doi=10.1016/j.autrev.2017.05.014}}</ref><ref name="pmid17303991">{{cite journal| author=Eberhardt RT, Dhadly M| title=Giant cell arteritis: diagnosis, management, and cardiovascular implications. | journal=Cardiol Rev | year= 2007 | volume= 15 | issue= 2 | pages= 55-61 | pmid=17303991 | doi=10.1097/01.crd.0000218853.05856.b6 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17303991  }} </ref>
*The concentric [[inflammation]] occurs in segments.<ref name="DiazDeBroff2005">{{cite journal|last1=Diaz|first1=Vicente A.|last2=DeBroff|first2=Brian M.|last3=Sinard|first3=John|title=Comparison of Histopathologic Features, Clinical Symptoms, and Erythrocyte Sedimentation Rates in Biopsy-Positive Temporal Arteritis|journal=Ophthalmology|volume=112|issue=7|year=2005|pages=1293–1298|issn=01616420|doi=10.1016/j.ophtha.2005.02.016}}</ref>
*[[Macrophage|Macrophages]] in the [[adventitia]] produce [[interleukin 6]]. While in the [[Tunica intima|intima]] and media of the [[Blood vessel|vessel]], [[Macrophage|macrophages]] produce [[Vascular endothelial growth factor|vascular endothelial growth factor (VEGF)]] and [[Metalloproteinase|metalloproteinases]] which destroy the [[internal elastic lamina]].<ref name="pmid17303991">{{cite journal| author=Eberhardt RT, Dhadly M| title=Giant cell arteritis: diagnosis, management, and cardiovascular implications. | journal=Cardiol Rev | year= 2007 | volume= 15 | issue= 2 | pages= 55-61 | pmid=17303991 | doi=10.1097/01.crd.0000218853.05856.b6 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17303991  }} </ref>
*An increased activated [[Platelet|platelets]] express [[P-selectin]] which may cause [[Blood vessel|vessel]] [[inflammation]] and [[Thrombosis|thromboembolic]] events.<ref name="pmid1634709">{{cite journal| author=Goodwin JS| title=Progress in gerontology: polymyalgia rheumatica and temporal arteritis. | journal=J Am Geriatr Soc | year= 1992 | volume= 40 | issue= 5 | pages= 515-25 | pmid=1634709 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1634709  }} </ref>
*Temporal arteritis arises from [[Macrophage|giant cells]], which are fused [[Monocyte|monocytes]] cells that are normally involved in the body [[Immune system|immune]] response.


It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
*Because the disease involves only arteries with [[internal elastic lamina]], the [[aortic arch]] and its branches are often involved. Intracranial [[Artery|arteries]] do not have [[internal elastic lamina]] and are not involved.
Commonly involved sites:<ref name="WaldmanWaldman2013">{{cite journal|last1=Waldman|first1=Corey W.|last2=Waldman|first2=Steven D.|last3=Waldman|first3=Reid A.|title=Giant Cell Arteritis|journal=Medical Clinics of North America|volume=97|issue=2|year=2013|pages=329–335|issn=00257125|doi=10.1016/j.mcna.2012.12.006}}</ref><ref name="PinelesArnold2007">{{cite journal|last1=Pineles|first1=Stacy L.|last2=Arnold|first2=Anthony C.|title=Giant Cell Arteritis|journal=International Ophthalmology Clinics|volume=47|issue=4|year=2007|pages=105–119|issn=0020-8167|doi=10.1097/IIO.0b013e318157fb08}}</ref><ref name="LiozonLy2013">{{cite journal|last1=Liozon|first1=E.|last2=Ly|first2=K.-H.|last3=Robert|first3=P.-Y.|title=Manifestations ophtalmologiques de la maladie de Horton|journal=La Revue de Médecine Interne|volume=34|issue=7|year=2013|pages=421–430|issn=02488663|doi=10.1016/j.revmed.2013.02.030}}</ref><ref name="pmid5078894">{{cite journal| author=Wilkinson IM, Russell RW| title=Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. | journal=Arch Neurol | year= 1972 | volume= 27 | issue= 5 | pages= 378-91 | pmid=5078894 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5078894  }} </ref> 


OR
*Cervicocephalic arteries: [[Carotid artery]] and [[vertebral artery]].  The [[vertebral artery]] is involved as frequently as the [[Superficial temporal artery|temporal artery]] in fatal cases. Involvement of the [[basilar artery]] is rare.


[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
*Intraorbital branches: Posterior ciliary artery and [[ophthalmic artery]].


OR
*External [[Common carotid artery|common]], [[External carotid artery|external]], and [[internal carotid artery]] involvement: It is less common for proximal intracranial [[Artery|arteries]] to be involved.


Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
*External [[Vertebral artery|vertebral arteries]]: It is less common though for the disease to extend more than 5 mm beyond the dural penetration.


OR
*[[Subclavian artery|Subclavian]], axially and proximal [[brachial artery]]: There can be typical [[Vasculitis|vasculitic]] lesions with long, smooth, lesions with tapered occlusions.


*[[Coronary arteries]]: For a full discussion of the involvement of the [[heart]] in this disorder see the chapter on [[The Heart in Temporal Arteritis / Giant Cell Arteritis]]


[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
Less commonly involved sites:<ref name="LiozonLy2013">{{cite journal|last1=Liozon|first1=E.|last2=Ly|first2=K.-H.|last3=Robert|first3=P.-Y.|title=Manifestations ophtalmologiques de la maladie de Horton|journal=La Revue de Médecine Interne|volume=34|issue=7|year=2013|pages=421–430|issn=02488663|doi=10.1016/j.revmed.2013.02.030}}</ref>


OR
*[[Descending aorta]]: [[Mesenteric artery|Mesenteric]], [[Iliac artery|iliac]], [[Femoral artery|femoral]] and [[Renal artery|renal arteries]] are less often involved. In these cases [[mesenteric ischemia]], [[renal infarction]], and [[Ischemia|ischemic]] [[mononeuropathy]] can occur.


The progression to [disease name] usually involves the [molecular pathway].
*[[Pulmonary artery]]
 
OR
 
The pathophysiology of [disease/malignancy] depends on the histological subtype.
 
==Pathophysiology==
===Pathogenesis===
*It is understood that temporal arteritis is the result of cell mediated immunity which arises as a response to endothelial injury.
*The adventitia of the vessel is the initial site of immunologic injury.
*Activation of dendritic cells in the adventitia causes a production of chemokines that recruit CD4+ T helper cells. The CD4+ T helper cell convert in to Th17 cells which produce interleukin 17 and Th1 cells which produce interferon gamma.
*Giant cell are one of many inflammatory cells that are recruited and produce growth factor which narrows and obstructs the vessels.[10][13]
*The concentric inflammation occurs in segments.[11]
*Macrophages in the adventia produce interleukin 6.[13] While in the intima and media of the vessel, macrophages produce vascular endothelial growth factor (VEGF) and metalloproteinases which destroy the internal elastic lamina.[12][13]
*An increased activated platelets express P-selectin which may cause vessel inflammation and thromboembolic events. [16]
*Temporal arteritis arises from giant cells, which are fused monocytes cells that are normally involved in the body immune response.


==Genetics==
==Genetics==
*[Disease name] is transmitted in [mode of genetic transmission] pattern.
*Temporal artertis has an association with the [[HLA-DR4]] [[haplotype]].<ref name="pmid19646354">{{cite journal| author=Liozon E, Ouattara B, Rhaiem K, Ly K, Bezanahary H, Loustaud V et al.| title=Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families. | journal=Clin Exp Rheumatol | year= 2009 | volume= 27 | issue= 1 Suppl 52 | pages= S89-94 | pmid=19646354 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19646354  }} </ref>
*Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
*An association between Toll-like receptor 4 gene [[polymorphism]] temporal arteritis has been found.<ref name="pmid19531762">{{cite journal| author=Palomino-Morales R, Torres O, Vazquez-Rodriguez TR, Morado IC, Castañeda S, Callejas-Rubio JL et al.| title=Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis. | journal=J Rheumatol | year= 2009 | volume= 36 | issue= 7 | pages= 1501-6 | pmid=19531762 | doi=10.3899/jrheum.081286 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19531762  }} </ref>
*The development of [disease name] is the result of multiple genetic mutations.


==Associated Conditions==
==Associated Conditions==
The disorder may coexist (in one quarter of cases) with [[polymyalgia rheumatica]] (PMR), which is characterized by a sudden onset of pain and stiffness in muscles ([[pelvis]], [[shoulder]]) of the body and seen in the elderly. Other diseases related with temporal arteritis are [[systemic lupus erythematosus]], [[rheumatoid arthritis]] and severe [[infection]]s.
*Temporal arteritis may coexist (in one quarter of cases) with [[polymyalgia rheumatica]] (PMR), which is characterized by a sudden onset of pain and stiffness in muscles ([[pelvis]], [[shoulder]]) of the body and seen in the elderly.<ref name="pmid24364483">{{cite journal| author=Caylor TL, Perkins A| title=Recognition and management of polymyalgia rheumatica and giant cell arteritis. | journal=Am Fam Physician | year= 2013 | volume= 88 | issue= 10 | pages= 676-84 | pmid=24364483 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24364483  }} </ref><ref name="SalvaraniCantini2008">{{cite journal|last1=Salvarani|first1=Carlo|last2=Cantini|first2=Fabrizio|last3=Hunder|first3=Gene G|title=Polymyalgia rheumatica and giant-cell arteritis|journal=The Lancet|volume=372|issue=9634|year=2008|pages=234–245|issn=01406736|doi=10.1016/S0140-6736(08)61077-6}}</ref> Other diseases related with temporal arteritis are [[systemic lupus erythematosus]], [[rheumatoid arthritis]] and severe [[infection]]s.<ref name="Alvarez-Lafuente2005">{{cite journal|last1=Alvarez-Lafuente|first1=R|title=Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction|journal=Annals of the Rheumatic Diseases|volume=64|issue=5|year=2005|pages=780–782|issn=0003-4967|doi=10.1136/ard.2004.025320}}</ref><ref name="pmid7880192">{{cite journal| author=Russo MG, Waxman J, Abdoh AA, Serebro LH| title=Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism? | journal=Arthritis Rheum | year= 1995 | volume= 38 | issue= 3 | pages= 374-80 | pmid=7880192 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7880192  }} </ref><ref name="GildenNagel2015">{{cite journal|last1=Gilden|first1=Don|last2=Nagel|first2=Maria|title=Varicella Zoster Virus in Temporal Arteries of Patients With Giant Cell Arteritis|journal=Journal of Infectious Diseases|volume=212|issue=suppl 1|year=2015|pages=S37–S39|issn=0022-1899|doi=10.1093/infdis/jiu542}}</ref>
 
==Gross Pathology==
*On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].


==Microscopic Pathology==
==Microscopic Pathology==
*On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
*On microscopic histopathological analysis the characteristic findings of temporal arteritis are:<ref name="pmid7728064">{{cite journal| author=Pountain G, Hazleman B| title=ABC of rheumatology. Polymyalgia rheumatica and giant cell arteritis. | journal=BMJ | year= 1995 | volume= 310 | issue= 6986 | pages= 1057-9 | pmid=7728064 | doi= | pmc=2549437 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7728064  }} </ref><ref name="pmid10817557">{{cite journal| author=Weyand CM, Fulbright JW, Hunder GG, Evans JM, Goronzy JJ| title=Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity. | journal=Arthritis Rheum | year= 2000 | volume= 43 | issue= 5 | pages= 1041-8 | pmid=10817557 | doi=10.1002/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10817557  }} </ref><ref name="pmid28275606">{{cite journal| author=Wang AL, Raven ML, Surapaneni K, Albert DM| title=Studies on the Histopathology of Temporal Arteritis. | journal=Ocul Oncol Pathol | year= 2017 | volume= 3 | issue= 1 | pages= 60-65 | pmid=28275606 | doi=10.1159/000449466 | pmc=5318845 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28275606  }} </ref>
 
**Skip lesions and normal intervening segments
==Pathophysiology==
**Intimal thickening, with prominent [[cellular infiltration]]
 
**[[Lymphocyte|Lymphocytes]] in the internal or external elastic lamina or [[adventitia]]
The damage to the vasculature is mediated by an attack on the internal elastica lamina by activated CD4+ [[T helper cell]]s.  This occurs in response to the presentation of an [[antigen]] by [[macrophages]]. The inciting antigen has not been identified.
**Areas of [[necrosis]] may be present in the [[Artery|arterial]] wall
 
**[[Granuloma|Granulomas]] containing [[Multinucleate|multinucleated]] [[Histiocyte|histiocytic]] and foreign body [[Macrophage|giant cells]], [[T helper cell|helper T-cell]] [[Lymphocyte|lymphocytes]], [[Plasma cell|plasma cells]], and [[Fibroblast|fibroblasts]]<ref name="pmid23523078">{{cite journal| author=Liozon E, Ly KH, Robert PY| title=[Ocular complications of giant cell arteritis]. | journal=Rev Med Interne | year= 2013 | volume= 34 | issue= 7 | pages= 421-30 | pmid=23523078 | doi=10.1016/j.revmed.2013.02.030 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23523078  }} </ref>
Because the disease involves only arteries with internal elastic lamina, the [[aortic arch]] and its branches are often involved. Intracranial arteries do not have internal elastic lamina and are not involved. The distribution of involved arteries are as follows:
 
Commonly involved sites:
 
*[[Cervicocephalic arteries]]: [[Carotid artery]] and [[vertebral artery]].  The [[vertebral artery]] is involved as frequently as the temporal artery in fatal cases. Involvement of the [[basilar artery]] is rare.


*Intraorbital branches: [[Posterior ciliary artery]] and [[ophthalmic artery]].
[[File:Giant cell arteritis -- low mag.jpg|400px|thumb|left|Giant cell arteritis-low mag [https://upload.wikimedia.org/wikipedia/commons/6/65/Giant_cell_arteritis_--_low_mag.jpg Source: Case courtesy of By Nephron [CC BY-SA 3.0, from Wikimedia Commons]]]
<br clear="left" />


*External [[Common carotid artery|common]], [[External carotid artery|external]], and [[internal carotid artery]] involvement: It is less common for proximal intracranial arteries to be involved.
====Video====
{{#ev:youtube|UrGsVfLbnA0}}


*External vertebral arteries: It is less common though for the disease to extend more than 5 mm beyond the dural penetration.
{{#ev:youtube|wBh4bI7Do3s}}
 
*[[Subclavian artery|Subclavian]], axially and [[proximal brachial artery]]: There can be typical vasculitic lesions with long, smooth, lesions with tapered occlusions.
 
*[[Coronary arteries]]: For a full discussion of the involvement of the heart in this disorder see the chapter on [[The Heart in Temporal Arteritis / Giant Cell Arteritis]]
 
Less commonly involved sites:
 
*[[Descending aorta]]: [[Mesenteric artery|Mesenteric]], [[Iliac artery|iliac]], [[Femoral artery|femoral]] and [[Renal artery|renal arteries]] are less often involved. In these cases [[mesenteric ischemia]], [[renal infarction]], and ischemic [[mononeuropathy]] can occur.
 
*[[Pulmonary artery]]


==References==
==References==
Line 89: Line 67:
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Needs overview]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 02:58, 16 April 2018

Temporal Arteritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Temporal Arteritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Temporal arteritis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Temporal arteritis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Temporal arteritis pathophysiology

CDC on Temporal arteritis pathophysiology

Temporal arteritis pathophysiology in the news

Blogs on Temporal arteritis pathophysiology

Directions to Hospitals Treating Temporal arteritis

Risk calculators and risk factors for Temporal arteritis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

Temporal arteritis is caused by transmural inflammation of elastic arteries. It is understood that temporal arteritis is the result of cell mediated immunity which arises as a response to endothelial injury and is antigen-driven disease with T-cell and macrophage activation in the elastic tissue in the arterial walls. The adventitia of the vessel is the initial site of immunologic injury. The activation of dendritic cells in the adventitia causes a production of chemokines that recruit CD4+ T helper cells. The CD4+ T helper cell convert in to Th17 cells which produce interleukin 17 and Th1 cells which produce interferon gamma. Giant cell are one of many inflammatory cells that are recruited and produce growth factor which narrows and obstructs the vessels. The concentric inflammation occurs in segments. Macrophages in the adventitia produce interleukin 6. While in the intima and media of the vessel, macrophages produce vascular endothelial growth factor (VEGF) and metalloproteinases which destroy the internal elastic lamina. An increased activated platelets express P-selectin which may cause vessel inflammation and thromboembolic events. Temporal arteritis arises from giant cells, which are fused monocytes cells that are normally involved in the body immune response. Because the disease involves only arteries with internal elastic lamina, the aortic arch and its branches are often involved. Intracranial arteries do not have internal elastic lamina and are not involved.

Pathophysiology

Pathogenesis

Commonly involved sites:[9][10][11][12]

  • External vertebral arteries: It is less common though for the disease to extend more than 5 mm beyond the dural penetration.

Less commonly involved sites:[11]

Genetics

Associated Conditions

Microscopic Pathology

Giant cell arteritis-low mag Source: Case courtesy of By Nephron [CC BY-SA 3.0, from Wikimedia Commons


Video

{{#ev:youtube|UrGsVfLbnA0}}

{{#ev:youtube|wBh4bI7Do3s}}

References

  1. ↑ Salvarani, C.; Pipitone, N.; Boiardi, L.; Hunder, G. G (2007). "Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?". Annals of the Rheumatic Diseases. 67 (5): 577–579. doi:10.1136/ard.2007.086330. ISSN 0003-4967.
  2. ↑ Pache M, Kaiser HJ, Haufschild T, Lübeck P, Flammer J (2002). "Increased endothelin-1 plasma levels in giant cell arteritis: a report on four patients". Am J Ophthalmol. 133 (1): 160–2. PMID 11755863.
  3. ↑ Patel SJ, Lundy DC (2002). "Ocular manifestations of autoimmune disease". Am Fam Physician. 66 (6): 991–8. PMID 12358224.
  4. ↑ 4.0 4.1 Wang AL, Raven ML, Surapaneni K, Albert DM (2017). "Studies on the Histopathology of Temporal Arteritis". Ocul Oncol Pathol. 3 (1): 60–65. doi:10.1159/000449466. PMC 5318845. PMID 28275606.
  5. ↑ Samson, Maxime; Corbera-Bellalta, Marc; Audia, Sylvain; Planas-Rigol, Ester; Martin, Laurent; Cid, Maria Cinta; Bonnotte, Bernard (2017). "Recent advances in our understanding of giant cell arteritis pathogenesis". Autoimmunity Reviews. 16 (8): 833–844. doi:10.1016/j.autrev.2017.05.014. ISSN 1568-9972.
  6. ↑ 6.0 6.1 Eberhardt RT, Dhadly M (2007). "Giant cell arteritis: diagnosis, management, and cardiovascular implications". Cardiol Rev. 15 (2): 55–61. doi:10.1097/01.crd.0000218853.05856.b6. PMID 17303991.
  7. ↑ Diaz, Vicente A.; DeBroff, Brian M.; Sinard, John (2005). "Comparison of Histopathologic Features, Clinical Symptoms, and Erythrocyte Sedimentation Rates in Biopsy-Positive Temporal Arteritis". Ophthalmology. 112 (7): 1293–1298. doi:10.1016/j.ophtha.2005.02.016. ISSN 0161-6420.
  8. ↑ Goodwin JS (1992). "Progress in gerontology: polymyalgia rheumatica and temporal arteritis". J Am Geriatr Soc. 40 (5): 515–25. PMID 1634709.
  9. ↑ Waldman, Corey W.; Waldman, Steven D.; Waldman, Reid A. (2013). "Giant Cell Arteritis". Medical Clinics of North America. 97 (2): 329–335. doi:10.1016/j.mcna.2012.12.006. ISSN 0025-7125.
  10. ↑ Pineles, Stacy L.; Arnold, Anthony C. (2007). "Giant Cell Arteritis". International Ophthalmology Clinics. 47 (4): 105–119. doi:10.1097/IIO.0b013e318157fb08. ISSN 0020-8167.
  11. ↑ 11.0 11.1 Liozon, E.; Ly, K.-H.; Robert, P.-Y. (2013). "Manifestations ophtalmologiques de la maladie de Horton". La Revue de Médecine Interne. 34 (7): 421–430. doi:10.1016/j.revmed.2013.02.030. ISSN 0248-8663.
  12. ↑ Wilkinson IM, Russell RW (1972). "Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement". Arch Neurol. 27 (5): 378–91. PMID 5078894.
  13. ↑ Liozon E, Ouattara B, Rhaiem K, Ly K, Bezanahary H, Loustaud V; et al. (2009). "Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families". Clin Exp Rheumatol. 27 (1 Suppl 52): S89–94. PMID 19646354.
  14. ↑ Palomino-Morales R, Torres O, Vazquez-Rodriguez TR, Morado IC, Castañeda S, Callejas-Rubio JL; et al. (2009). "Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis". J Rheumatol. 36 (7): 1501–6. doi:10.3899/jrheum.081286. PMID 19531762.
  15. ↑ Caylor TL, Perkins A (2013). "Recognition and management of polymyalgia rheumatica and giant cell arteritis". Am Fam Physician. 88 (10): 676–84. PMID 24364483.
  16. ↑ Salvarani, Carlo; Cantini, Fabrizio; Hunder, Gene G (2008). "Polymyalgia rheumatica and giant-cell arteritis". The Lancet. 372 (9634): 234–245. doi:10.1016/S0140-6736(08)61077-6. ISSN 0140-6736.
  17. ↑ Alvarez-Lafuente, R (2005). "Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction". Annals of the Rheumatic Diseases. 64 (5): 780–782. doi:10.1136/ard.2004.025320. ISSN 0003-4967.
  18. ↑ Russo MG, Waxman J, Abdoh AA, Serebro LH (1995). "Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism?". Arthritis Rheum. 38 (3): 374–80. PMID 7880192.
  19. ↑ Gilden, Don; Nagel, Maria (2015). "Varicella Zoster Virus in Temporal Arteries of Patients With Giant Cell Arteritis". Journal of Infectious Diseases. 212 (suppl 1): S37–S39. doi:10.1093/infdis/jiu542. ISSN 0022-1899.
  20. ↑ Pountain G, Hazleman B (1995). "ABC of rheumatology. Polymyalgia rheumatica and giant cell arteritis". BMJ. 310 (6986): 1057–9. PMC 2549437. PMID 7728064.
  21. ↑ Weyand CM, Fulbright JW, Hunder GG, Evans JM, Goronzy JJ (2000). "Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity". Arthritis Rheum. 43 (5): 1041–8. doi:10.1002/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7. PMID 10817557.
  22. ↑ Liozon E, Ly KH, Robert PY (2013). "[Ocular complications of giant cell arteritis]". Rev Med Interne. 34 (7): 421–30. doi:10.1016/j.revmed.2013.02.030. PMID 23523078.


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Temporal_arteritis_pathophysiology&oldid=1462845"